Knoll Capital Management, LLC Anavex Life Sciences Corp. Transaction History

Knoll Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.31 - $12.84 $1.54 Million - $2.71 Million	-210,789 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$9.74 - $17.69 $2.05 Million - $3.73 Million	210,789 New	210,789 $2.6 Million
Q1 2021 Jun 14, 2021	SELL	$5.17 - $16.13 $3.47 Million - $10.8 Million	-670,789 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.01 - $7.58 $200,500 - $379,000	50,000 Added 8.05%	670,789 $3.62 Million
Q3 2020 Nov 16, 2020	SELL	$3.8 - $5.0 $392,980 - $517,080	-103,416 Reduced 14.28%	620,789 $2.83 Million
Q3 2017 Nov 14, 2017	BUY	$3.42 - $4.87 $2.48 Million - $3.53 Million	724,205	724,205 $3 Million

163

27.5M

515K

838K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $673M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Knoll Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Knoll Capital Management, LLC with notifications on news.